GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fabino Life Sciences Ltd (BOM:543444) » Definitions » Debt-to-Asset

Fabino Life Sciences (BOM:543444) Debt-to-Asset : 0.08 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Fabino Life Sciences Debt-to-Asset?

Fabino Life Sciences's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹0.0 Mil. Fabino Life Sciences's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹12.7 Mil. Fabino Life Sciences's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was ₹153.6 Mil. Fabino Life Sciences's debt to asset for the quarter that ended in Mar. 2024 was 0.08.


Fabino Life Sciences Debt-to-Asset Historical Data

The historical data trend for Fabino Life Sciences's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fabino Life Sciences Debt-to-Asset Chart

Fabino Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-Asset
Get a 7-Day Free Trial 0.30 0.14 0.01 0.08 0.08

Fabino Life Sciences Semi-Annual Data
Mar19 Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24
Debt-to-Asset Get a 7-Day Free Trial 0.01 0.01 0.08 0.14 0.08

Competitive Comparison of Fabino Life Sciences's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Fabino Life Sciences's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fabino Life Sciences's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fabino Life Sciences's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Fabino Life Sciences's Debt-to-Asset falls into.



Fabino Life Sciences Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Fabino Life Sciences's Debt-to-Asset for the fiscal year that ended in Mar. 2024 is calculated as

Fabino Life Sciences's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fabino Life Sciences  (BOM:543444) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Fabino Life Sciences Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Fabino Life Sciences's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Fabino Life Sciences (BOM:543444) Business Description

Traded in Other Exchanges
N/A
Address
Murthal Road,, Shubham Garden, Jeevan Vihar Extension Near, Sonipat, HR, IND, 131001
Fabino Life Sciences Ltd is a pharmaceutical company. It is engaged in manufacturing, marketing, trading and packing of pharmaceutical and other wellness-focused consumer products. It offers a wide range of allopathic, Food and wellness, Veterinary, Multi-vitamin and herbal products. The company currently supplies in Haryana, Delhi, parts of Punjab, Himachal Pradesh, Eastern Uttar Pradesh, Orissa, and Jharkhand, and parts of West Bengal, Andhra Pradesh, and Nepal.

Fabino Life Sciences (BOM:543444) Headlines

No Headlines